A patient in New York has been infected with a strain of E. coli highly resistant to last-resort antibiotic treatments, according to an article on the Becker's Infection Control and Clinical Quality website.
This is the second U.S. patient with the untreatable superbug infection, following a Pennsylvania patient first made public last month.
The mcr-1 gene gives bacteria resistance to colistin, a last-line-of-defense antibiotic used to combat a number of resistant microorganisms.
Going into 2017, the White House has requested $1.1 billion be allocated to efforts to combat antibiotic resistance in the U.S.
Designing a Home Away from Home
Stephens County Hospital Becoming Part of Wellstar Health System
Grafton City Hospital Joins Vandalia Health
Protecting Patients from C. auris Through Bed and Mattress Safety
Geisinger Wyoming Valley Medical Center Tops Off New Acute Care Tower